Effect of the hemodialysis membrane on the inflammatory reaction in vivo

Clinical Nephrology

Volumn 53, Issue 6, 2000, Pages 452-459

  Schindler, R ^a   Boenisch, O ^a   Fischer, C ^a   Frei, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Hemodialysis membrane; Inflammation; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN; CUPROPHANE; POLYCARBONATE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; IN VIVO STUDY; INFLAMMATION; KIDNEY FUNCTION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; PERIPHERAL VASCULAR DISEASE;

BIOCOMPATIBLE MATERIALS; C-REACTIVE PROTEIN; CELLULOSE; CROSS-OVER STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; INTERLEUKINS; KIDNEY DISEASES; MEMBRANES, ARTIFICIAL; MIDDLE AGED; NYLONS; POLYCARBOXYLATE CEMENT; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 0034041483     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ballou SP, Lozanski G 1992 Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4: 361-368
2. Bloembergen WE, Hakim RM, Stannard DC et al 1999 Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 33: 1-10
3. Bologa RM, Levine PM, Parker TS et al 1998 Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32: 107-114
4. Charney DI, Walton DF, Cheung AK 1993 Atherosclerosis in chronic renal failure. Curr Opin Nephrol Hypertens 2: 876-882
5. Descamps Latscha B, Herbelin A, Nguyen AT et al 1995 Balance between IL-1-beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154: 882-892
6. Dinarello CA, Lonnemann G, Maxwell R, Shaldon S 1987 Ultrafiltration to reject human interleukin-I-inducing substances derived from bacterial cultures. J Clin Microbiol 25: 1233-1238
7. Docci D, Bilancioni R, Buscaroli A et al 1990 Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron 56: 364-367
8. Dong Q, Wright JR 1996 Expression of C-reactive protein by alveolar macrophages. J Immunol 156: 4815-4820
9. Gotschlich EC, Edelman GM 1965 C-reactive protein: a molecule composed of subunits. Proc Natl Acad Sci USA 54: 558-566
10. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM 1996 Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 16: 158-162
11. Haubitz M, Schulze M, Koch KM 1990 Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 5: 500-503
12. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB 1997 Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group (see comments). Lancet 349: 462-466
13. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps LB 1990 Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 37: 116-125
14. Herzog CA, Ma JZ, Collins AJ 1998 Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805
15. Honkanen E, Gronhagen Riska C, Teppo AM, Maury CP, Meri S 1991 Acute-phase proteins during hemodialysis: correlations with serum interleukin-1-beta levels and different dialysis membranes. Nephron 57: 283-287
16. Innes A, Charra B, Burden RP, Morgan AG, Laurent G 1999 The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 14: 919-922
17. Iseki K, Kawazoe N, Fukiyama K 1993 Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44: 115-119
18. Kaysen GA, Stevenson FT, Depner TA 1997 Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29: 658-668
19. Koda Y, Nishi S, Miyazaki S et al 1997 Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 52: 1096-1101
20. Lagrand WK, Niessen HW, Wolhink GJ et al 1997 C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95: 97-103
21. Lonnemann G, Mahiout A, Schindler R, Colton CK 1992 Pyrogen retention by the polyamide membranes. Contrib Nephrol 96: 47-63
22. Lowrie EG, Lew NL 1990 Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482
23. Lufft V, Mahiout A, Shaldon S. Koch KM, Schindler R 1996 Retention of cytokine-inducing substances inside high flux dialyzers. Blood Purif 14: 26-34
24. McIntyre C, Harper I, Macdougall IC, Raine AE, Williams A, Baker LR 1997 Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol 48: 371-374
25. Oliveira EB, Gotschlich C, Liu TY 1979 Primary structure of human C-reactive protein. J Biol Chem 254: 489-502
26. Owen WF, Lowrie EG 1998 C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54: 627-636
27. Pereira BJ, Poutsiaka DD, King AJ et al 1992 In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 42: 1419-1424
28. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello, CA 1994 Plasma levels of IL-1-beta, TNF-alpha and their specific inhibitors in undialyzed chronic renal failure, CARD and hemodialysis patients. Kidney Int 45: 890-896
29. Pue CA, Mortensen RF, Marsh CB, Pope HA, Wewers MD 1996 Acute phase levels of C-reactive protein enhance IL-1-beta and IL-1-ra production by human blood monocytes but inhibit EL-1-beta and EL-1-ra production by alveolar macrophages. J Immunol 156: 1594-1600
30. Qureshi AR, Alvestrand A, Danielsson A et al 1998 Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 53: 773-782
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men (see comments; published erratum appears in N Engl J Med 1997 Jul 31, 337: 356). N Engl J Med 336: 973-979
32. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH 1998 Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97: 425-428
33. Ross R 1999 Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126
34. Schindler R, Gelfand JA, Dinarello CA 1990 Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76: 1631-1638
35. Schindler R, Linnennweber S, Schulze M et al 1993 Gene expression of interleukin-1-beta during hemodialysis. Kidney Int 43: 712-721
36. Schindler R, Lonnemann G, Schliffer J, Shaldon S, Koch KM, Krautzig S 1994 The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 68: 229-233
37. Stenvinkel P, Heimburger O, Paultre F et al 1999 Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911
38. Vaith P, Prasauskas V, Potempa LA, Peter HH 1996 Complement activation by C-reactive protein on the HEp-2 cell substrate. Int Arch Allergy Immunol 111: 107-117
39. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE 1996 CRP-mediated activation of complement in vivo: assessment by measuring circulating complement C-reactive protein complexes. J Immunol 157: 473-479
40. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C 1999 Inflammation enhances cardiovascular risk and mortality in hemodialysis. Kidney Int 55: 648-658